Dr. Choudhury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N St. Clair Street
Suite 19-100
Chicago, IL 60611Phone+1 312-695-4965
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Cardiovascular Disease, 1998 - 2001
- Wayne State University School of MedicineResidency, Internal Medicine, 1995 - 1998
- Hammersmith Hospital, Imperial College London, UKFellowship, Cardiology Research Fellow, 1991 - 1994
- National University of Ireland, GalwayClass of 1986, MBBChBAO, Honors, 4th place in Class
Certifications & Licensure
- IL State Medical License 1998 - 2026
- MI State Medical License 1995 - 1998
- American Board of Internal Medicine Cardiovascular Disease
- Certification Board of Nuclear CardiologyNuclear Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy Start of enrollment: 2014 Apr 01
- A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) Start of enrollment: 2018 Mar 30
Publications & Presentations
PubMed
- 4 citationsImpact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.Martin S Maron, Ahmad Masri, Michael E Nassif, Roberto Barriales-Villa, Theodore P Abraham
Journal of the American College of Cardiology. 2024-11-05 - 1 citationsStandard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.Ahmad Masri, Lubna Choudhury, Roberto Barriales-Villa, Perry Elliott, Martin S Maron
Journal of the American College of Cardiology. 2024-11-05 - 5 citationsEfficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.Ahmad Masri, Mark V Sherrid, Theodore P Abraham, Lubna Choudhury, Pablo Garcia-Pavia
Journal of Cardiac Failure. 2024-11-01
Journal Articles
- Late Gadolinium Enhancement and Extracellular Volume Fraction Between Sarcomeric Mutation Positive and Negative Hypertrophic CardiomyopathySirish Vullaganti, Lubna Choudhury, Journal of Cardiac Failure
Authored Content
- Late Gadolinium Enhancement and Extracellular Volume Fraction Between Sarcomeric Mutation Positive and Negative Hypertrophic CardiomyopathyAugust 2018
Professional Memberships
- Fellow
- Premium Professional Member
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: